[1]潘静夫,李素霞,宋传莲,等.小剂量靛玉红为主治疗慢性粒细胞白血病[J].新乡医学院学报,1992,9(02):127-128.

点击复制

小剂量靛玉红为主治疗慢性粒细胞白血病/HTML

分享到：

相似文献/References:

[1]潘静夫,赵媛英.小剂量靛玉红和马利兰治疗——慢性粒细胞性白血病疗效观察[J].新乡医学院学报,1988,5(03):039.
[2]王慧睿,郭淑利,李　波,等.伊马替尼和达沙替尼治疗初发慢性粒细胞白血病慢性期患者疗效观察[J].新乡医学院学报,2018,35(6):495.[doi:10.7683/xxyxyxb.2018.06.011]
　WANG Hui-rui,GUO Shu-li,LI Bo,et al.Comparison of the efficacy of imatinib and dasatinib for treatment of newly diagnosed chronic myelogenous leukemia chronic phase patients[J].Journal of Xinxiang Medical University,2018,35(02):495.[doi:10.7683/xxyxyxb.2018.06.011]
[3]王慧睿,郭淑利,李　波,等.伊马替尼治疗后慢性粒细胞白血病患者BCR-ABL酪氨酸激酶区突变特征分析[J].新乡医学院学报,2017,34(6):489.[doi:10.7683/xxyxyxb.2017.06.009]
　WANG Hui-rui,GUO Shu-li,LI Bo,et al.Characteristics of BCR-ABL tyrosine kinase domain point mutations in imatinib treated chronic myeloid leukemia patients[J].Journal of Xinxiang Medical University,2017,34(02):489.[doi:10.7683/xxyxyxb.2017.06.009]